Opposing roles for SNAP23 and SNAP25 in mediating MR1 trafficking and antigen presentation

This study reveals that SNAP23 and SNAP25 play opposing roles in MR1-mediated antigen presentation to MAIT cells, where SNAP23 facilitates the trafficking and presentation of microbial antigens while SNAP25 suppresses this process.

The Gist

Imagine your body is a bustling city, and its immune system is the police force. One of the most important jobs of the police is to spot criminals (bacteria and fungi) and sound the alarm. To do this, they use "wanted posters" displayed on the surface of their buildings.

In this scientific story, the "wanted poster" is a molecule called MR1. Its job is to show a tiny piece of a criminal (a metabolite from bacteria like Mycobacterium tuberculosis or Candida albicans) to a special type of police officer called MAIT cells. When the MAIT cells see the poster, they know to attack the infection.

But how does the poster get from the "printing press" inside the cell to the "billboard" on the outside? That's where our two main characters come in: SNAP23 and SNAP25.

Think of these two proteins as delivery truck drivers who work in the same garage but have very different, almost opposite, personalities.

The Two Drivers: SNAP23 and SNAP25

1. SNAP23: The Helpful Delivery Driver
SNAP23 is like a hardworking, reliable truck driver who loves to keep the fleet moving.

• What it does: It helps build and maintain the fleet of delivery trucks (vesicles) that carry the MR1 posters.
• The Result: When SNAP23 is doing its job, the cell has plenty of trucks, and the "wanted posters" for tuberculosis (Mtb) get displayed efficiently.
• What happens if it's gone? If you remove SNAP23 (like firing the driver), the garage runs out of trucks. The number of MR1 posters drops, and the cell can't show the "wanted" sign for tuberculosis effectively. The immune system gets confused and misses the threat.

2. SNAP25: The Traffic Jam Creator
SNAP25 is like a driver who is actually too cautious. It tends to block the road or hold the trucks back.

• What it does: It acts as a brake on the system. It stops the MR1 posters from reaching the surface too quickly or too often.
• The Result: When SNAP25 is present, the "wanted posters" for all kinds of germs (both inside and outside the cell) are displayed less often. It's like putting a "Closed for Maintenance" sign on the billboard.
• What happens if it's gone? If you remove SNAP25 (like firing the traffic cop), the brake is released! Suddenly, the trucks zoom to the surface. The cell displays more MR1 posters, making it easier for the immune system to spot and fight off infections like tuberculosis, Candida (yeast), and other bacteria.

The Big Discovery: Opposing Forces

The researchers found that these two drivers are constantly fighting over who controls the traffic.

• SNAP23 says, "Let's get these posters out there! We need to fight the bacteria!"
• SNAP25 says, "Hold on, let's slow down. We don't need to show them off yet."

In the specific case of tuberculosis, SNAP23 is the hero that helps the immune system see the enemy. But SNAP25 is the villain that tries to hide the enemy. When the scientists removed SNAP25, the immune system became super-alert and showed even more posters, making the cell better at fighting the infection.

Why Does This Matter?

Think of it like a dimmer switch on a light.

• SNAP23 turns the light up for specific bacterial threats.
• SNAP25 turns the light down for almost everything.

Understanding this tug-of-war helps scientists figure out how to tweak the immune system. If we can figure out how to boost SNAP23 or turn down SNAP25, we might be able to help the body fight off stubborn infections like tuberculosis or fungal infections more effectively.

In a nutshell: This paper discovered that two similar-looking proteins act like a gas pedal and a brake pedal for the immune system's "wanted posters." One helps the body see the germs, while the other tries to hide them. Knowing how they work together (or fight each other) gives us a new way to think about boosting our natural defenses.

Technical Summary

1. Problem Statement

MHC class I-related protein 1 (MR1) presents small-molecule metabolites from microbial pathogens to Mucosal-Associated Invariant T (MAIT) cells, playing a critical role in immune defense. Previous research established that MR1 trafficking involves endosomal compartments and relies on Synaptotagmin (Syt) proteins (Syt1 and Syt7) which sense endosomal calcium. However, the specific roles of their binding partners, the Synaptosome-Associated Proteins (SNAPs), in MR1-mediated antigen presentation remained undefined. While SNAP23 and SNAP25 are known to form SNARE complexes with Syntaxins and VAMPs to facilitate membrane fusion, their distinct and potentially opposing contributions to MR1 trafficking and antigen presentation in non-neuronal cells were unknown.

2. Methodology

The study utilized the human bronchial epithelial cell line BEAS-2B as the primary model system. The experimental approach included:

• Genetic Manipulation:
  • siRNA Knockdown: Transient knockdown of four SNAP homologs (SNAP23, SNAP25, SNAP29, SNAP47) to screen for effects on antigen presentation.
  • CRISPR/Cas9 Knockout (KO): Generation of stable clonal cell lines lacking SNAP23 or SNAP25 to confirm findings and eliminate off-target effects. A specific clonal line was created in a BEAS-2B MR1-KO background stably expressing tetracycline-inducible GFP-tagged MR1 (TET-MR1-GFP) to allow precise tracking of MR1 vesicles.
• Antigen Presentation Assays:
  • Cells were infected with intracellular pathogens (Mycobacterium tuberculosis [Mtb], Mycobacterium avium) or extracellular pathogens (Candida albicans).
  • Supernatants from M. smegmatis, C. albicans, and M. avium were used to test exogenous antigen presentation.
  • ELISpot Assays: Co-culture of infected BEAS-2B cells with specific T cell clones (MAIT cells for MR1-restricted antigens; HLA-B45-restricted T cells for control) to measure IFN-$\gamma$ release as a proxy for antigen presentation efficiency.
• Cellular Trafficking and Localization Analysis:
  • Flow Cytometry: Measured surface expression of MR1 and HLA-Ia using specific antibodies. Used Brefeldin A (BFA) to block anterograde transport and measure MR1 internalization/decay rates.
  • Fluorescence Microscopy: Visualized MR1-GFP vesicles in SNAP23 KO cells. Co-localization studies were performed using RFP-tagged Rab5a (early endosomes) and LAMP1 (lysosomes).
  • Uptake and Viability Assays: Used auxotrophic Mtb expressing GFP (AuxMtb) and fluorescent beads to assess phagocytosis. Colony-Forming Unit (CFU) assays measured intracellular Mtb viability. pHrodo dextran was used to assess endosomal acidity.
• Molecular Validation: RT-qPCR, Western Blotting, and ICE (Inference of CRISPR Edits) analysis confirmed gene knockdown/knockout efficiency.

3. Key Contributions

• Identification of Opposing Mechanisms: The study is the first to demonstrate that SNAP23 and SNAP25, despite sharing 55% sequence homology, exert opposing regulatory effects on MR1 antigen presentation.
• Pathogen-Specific Regulation: It reveals that SNAP23 is specifically required for Mtb presentation but not for extracellular pathogens like C. albicans, whereas SNAP25 acts as a universal suppressor of MR1 presentation across diverse pathogens.
• Mechanistic Distinction: The authors delineate two distinct mechanisms:
  1. SNAP23 regulates the quantity of MR1-containing vesicles available for trafficking.
  2. SNAP25 regulates the surface stabilization of ligand-loaded MR1, acting as a negative regulator.

4. Key Results

A. Differential Roles in Antigen Presentation

• SNAP23: Knockdown or knockout of SNAP23 significantly reduced MR1-mediated presentation of Mtb antigens to MAIT cells. It had no effect on exogenous antigen presentation (M. smeg supernatant) or HLA-B45 presentation.
• SNAP25: Conversely, knockout of SNAP25 enhanced MR1 presentation of Mtb, M. avium, and C. albicans (both intracellular and extracellular sources). This suggests SNAP25 normally functions to suppress MR1 presentation.
• Other SNAPs: SNAP29 knockdown impaired both MR1 and HLA-Ia presentation (non-specific), while SNAP47 had no effect.

B. Mechanisms of Action

• SNAP23 and Vesicle Quantity:
  • SNAP23 KO cells showed a significant reduction in the total number of MR1+ vesicles at baseline.
  • This reduction persisted during Mtb infection or bead uptake.
  • Co-localization analysis showed MR1 vesicles still localized primarily to LAMP1 (lysosomes) and not Rab5a, indicating SNAP23 loss does not reroute MR1 to wrong compartments but simply reduces the vesicle pool size.
  • SNAP23 KO did not affect Mtb uptake or phagocytosis of beads.
• SNAP25 and Surface Stabilization:
  • SNAP25 KO cells displayed enhanced surface translocation of MR1 when loaded with the ligand 6-FP (6-formylpterin), without changes in total cellular MR1 levels.
  • BFA decay assays showed that SNAP25 KO did not alter the rate of MR1 internalization, suggesting SNAP25 suppresses the delivery or stabilization of loaded MR1 at the surface rather than promoting its removal.
  • Interestingly, SNAP25 KO led to increased intracellular Mtb viability, potentially increasing antigen availability, though this was independent of endosomal pH changes.

C. Specificity

• The regulatory role of SNAP23 was specific to Mtb; it did not affect presentation of C. albicans or M. avium.
• The suppressive role of SNAP25 was broad, affecting presentation of all tested microbes except for M. avium supernatant (which was weakly antigenic).

5. Significance

• Novel Regulatory Layer: This study expands the understanding of MR1 trafficking beyond calcium-sensing proteins (Syt1/7) to include the SNAP family, identifying a new layer of regulation where specific SNAP isoforms act as "brakes" (SNAP25) or "accelerators" (SNAP23) for antigen presentation.
• Context-Dependent Function: It highlights that SNAP proteins do not function uniformly; their impact depends on the specific pathogen and the cellular context (e.g., bronchial epithelium vs. neurons).
• Therapeutic Implications: Understanding how SNAP23 and SNAP25 differentially regulate MR1 could inform strategies to modulate MAIT cell responses. For instance, inhibiting SNAP25 could potentially boost MR1-mediated immunity against a broad range of pathogens, while enhancing SNAP23 function might be specific to improving anti-tuberculosis immunity.
• Mechanistic Insight: The findings suggest that the competition between SNAP23 and SNAP25 for binding partners (like Syntaxins) or their distinct membrane affinities may drive these opposing effects, offering a model for how vesicular trafficking is fine-tuned in immune cells.

In conclusion, the paper establishes that SNAP23 is a positive regulator essential for maintaining the pool of MR1 vesicles for Mtb presentation, while SNAP25 is a negative regulator that suppresses MR1 surface expression and presentation across multiple pathogens.